Live from the NIH registry
Studies recruiting near Trenton right now
Top 25 of 2,347 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital — New Brunswick, New Jersey (24.5 mi)
· Sponsor: National Cancer Institute (NCI)
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Penn Medicine Princeton Medical Center — Plainsboro, New Jersey (11.5 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Penn Prevention — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Westat
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
N/A
Interventional 300 participants sought
University of Pennsylvania — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Airiver Medical, Inc.
The ED-AWARENESS-2 Trial
Awareness, Mechanical Ventilation
N/A
Interventional 3,090 participants sought
Cooper University Hospital/Cooper Medical School of Rowan University — Camden, New Jersey (27.9 mi)
· Sponsor: Washington University School of Medicine
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Stroke, Cerebrovascular Accident
N/A
Interventional 150 participants sought
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute — Edison, New Jersey (27.5 mi)
· Sponsor: Hackensack Meridian Health
LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study
LCAT Deficiency
N/A
Observational 40 participants sought
University of Pennsylvania — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: University of Pennsylvania
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Thomas Jefferson University Hospital- Site Number : 8400002 — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Sanofi
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
Abramson Cancer Center of the University of Pennsylvania ( Site 0010) — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey (24.5 mi)
· Sponsor: Regeneron Pharmaceuticals
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Abington, Pennsylvania (20.0 mi)
· Sponsor: AstraZeneca
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
Osteoporotic Fractures, Osteoporosis
N/A
Observational 648 participants sought
Thomas Jefferson University Hospital — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: AO Foundation, AO Spine
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Virtua Samson Cancer Center — Moorestown, New Jersey (20.1 mi)
· Sponsor: SWOG Cancer Research Network
A Prospective Natural History Study of Lymphatic Anomalies
Lymphatic Diseases, Lymphatic Abnormalities
N/A
Observational 1,200 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Tebentafusp-tebn With LDT in Metastatic UM
Metastatic Uveal Melanoma
Phase 1, Phase 2
Interventional 109 participants sought
Thomas Jefferson University — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Thomas Jefferson University
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
Smoking Cessation
N/A
Interventional 50 participants sought
Institute for Nicotine & Tobacco Studies — New Brunswick, New Jersey (24.5 mi)
· Sponsor: Rutgers, The State University of New Jersey
The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction
ACL Repair
N/A
Interventional 20 participants sought
Virtua Orthopedics Burlington — Burlington, New Jersey (11.8 mi)
· Sponsor: Virtua Health, Inc.
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Jaeb Center for Health Research
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Rutgers Cancer Institute — New Brunswick, New Jersey (24.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry
Spinal Dural Arteriovenous Fistula
N/A
Observational 1,000 participants sought
Thomas Jefferson University Hospital — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Thomas Jefferson University
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Astera Cancer Care — East Brunswick, New Jersey (23.1 mi)
· Sponsor: Guardant Health, Inc.
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: AstraZeneca
Point of Care STI Testing
Point of Care STI Testing
N/A
Interventional 6,460 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Icahn School of Medicine at Mount Sinai
Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study
Esophageal Atresia With Tracheo-esophageal Fistula, Esophageal Atresia
N/A
Interventional 128 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Boston Children's Hospital
CEUS for Blunt Abdominal Trauma in Children
Trauma Abdomen
Phase 4
Interventional 146 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Children's Hospital of Philadelphia